2Suppliers
2Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Regentis Biomaterials Ltd. (RGNT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships
2Distinct source URLs
4High confidence
0.785Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Regentis Biomaterials Ltd. Suppliers

TickerNameConfidenceEvidence
CLGN CollPlant Biotechnologies Ltd. 72% Reciprocal relationship from CLGN graph: Reciprocal relationship from RGNT graph: Reciprocal relationship from CLGN graph: Reciprocal relationship from RGNT graph: Reciprocal relationship from CLGN g…
PRFX PRF Technologies Ltd. 72% Reciprocal relationship from PRFX graph: s, liabilities and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accoun…

Regentis Biomaterials Ltd. Customers

TickerNameConfidenceEvidence
BAX Baxter International Inc. 62% Reciprocal relationship from BAX graph: Reciprocal relationship from RGNT graph: Reciprocal relationship from BAX graph: Reciprocal relationship from RGNT graph: Reciprocal relationship from BAX grap…
MEDICA-VENTURE-PARTNERS MEDICA-VENTURE-PARTNERS 62% sses. For example, our Chairman and Chief Executive Officer is employed by Medica Venture Partners. If our directors’ and other officers’ other business affairs require them to devote substantial amo…

Regentis Biomaterials Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RGNT-DEBT Debt stack $1.2M 90% Market cache reports total debt of $1.2M.
RGNT-DEBT-12158 Warrants outstanding: 0.004 90% xbrl warrant detail from xbrl 2025-12-31.
RGNT-DEBT-12159 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.

Regentis Biomaterials Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Regentis Biomaterials Ltd..

Regentis Biomaterials Ltd. Ownership

HolderNameConfidenceEvidence
RGNT-OWNER-AIGH-CAPITAL-MANAGEMENT-LLC AIGH Capital Management LLC 90% 13F overlay lists AIGH Capital Management LLC as top holder; 3 tracked holders.

Regentis Biomaterials Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
PRFX PRF Technologies Ltd. 100.00 1 ['supplier']
BAX Baxter International Inc. 100.00 1 ['customer']
ESTA Establishment Labs Holdings Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 1 ['supplier']
ENLV Enlivex Ltd. 100.00 2
IMCC IM Cannabis Corp. 100.00 2
JNJ Johnson & Johnson 100.00 2
KLIC Kulicke and Soffa Industries, Inc. 100.00 2
FMCQF Fresenius Medical Care AG 50.00 2
KMDA Kamada Ltd. 50.00 2
AORT Artivion, Inc. 50.00 2
HSCS HeartSciences Inc. 50.00 2
NUWE Nuwellis, Inc. 50.00 2
MDWD MediWound Ltd. 50.00 2
SNN Smith & Nephew plc 50.00 2
HRTX Heron Therapeutics, Inc. 50.00 2
ALC Alcon Inc. 50.00 2
ELMD Electromed, Inc. 50.00 2
ORANY ORANGE 50.00 2
IRTC iRhythm Holdings, Inc. 50.00 2
🔐
RGNT
Unlock RGNT Supply Chain Data
Verified relationships include:
CLGNCollPlant Biotechnologies Ltd.Supplier72%
PRFXPRF Technologies Ltd.Supplier72%
BAXBaxter International Inc.Customer62%
MEDICA-VENTURE-PARTNERSMEDICA-VENTURE-PARTNERSCustomer62%
+4 more relationships locked
Subscribe, View plans →